• Income Statement
• Balance Sheet
• Cash Flow
• Ratios
• Market Data
• Valuation

	Medinotec Inc. (MDNC)
	Q1-CY2026	Q4-CY2025	Q3-CY2025	Q2-CY2025	Q1-CY2025	Q4-CY2024	Q3-CY2024	Q2-CY2024	Q1-CY2024	Q4-CY2023	Q3-CY2023	Q2-CY2023	Q1-CY2023	Q4-CY2022	Q3-CY2022	Q2-CY2022	Q1-CY2022	Q4-CY2021	Q3-CY2021	Q2-CY2021	Q1-CY2021	Q4-CY2020	Q3-CY2020	Q2-CY2020	Q1-CY2020	Q4-CY2019	Q3-CY2019	Q2-CY2019	Q1-CY2019	Q4-CY2018	Q3-CY2018	Q2-CY2018	Q1-CY2018	Q4-CY2017	Q3-CY2017	Q2-CY2017	Q1-CY2017	Q4-CY2016	Q3-CY2016	Q2-CY2016	Q1-CY2016	Q4-CY2015	Q3-CY2015	Q2-CY2015	Q1-CY2015	Q4-CY2014	Q3-CY2014	Q2-CY2014	Q1-CY2014
Balance Sheet Date		2025-Nov-30	2025-Aug-31	2025-May-31	2025-Feb-28	2024-Nov-30	2024-Aug-31	2024-May-31	2024-Feb-29	2023-Nov-30
Fiscal Period		Q3-FY2026	Q2-FY2026	Q1-FY2026	Q4-FY2025	Q3-FY2025	Q2-FY2025	Q1-FY2025	Q4-FY2024	Q3-FY2024
Total Revenue		2,536,994$	3,236,305$	2,134,026$	3,525,162$	2,565,048$	1,804,020$	1,251,878$	2,250,844$	2,002,547$	350,792$	416,208$	279,240$	387,989$
QoQ%		(21.61%)	51.65%	(39.46%)	37.43%	42.19%	44.11%	(44.38%)	12.40%	470.87%	(15.72%)	49.05%	(28.03%)
YoY%		(1.09%)	79.39%	70.47%	56.62%	28.09%	414.27%	200.78%	706.06%	416.14%
Cost Of Revenue		1,190,942$	1,234,132$	(1,208,695$)	(7,366,800$)	1,524,272$	970,608$	(651,599$)	(3,876,038$)	1,138,628$	60,988$	(98,498$)	(717,899$)	164,685$
Gross Profit		1,346,052$	2,002,173$	925,331$	2,386,320$	1,040,776$	833,412$	600,279$	971,038$	863,919$	289,804$	317,710$	161,625$	223,304$
Gross Margin		53.06%	61.87%	43.36%	67.69%	40.58%	46.20%	47.95%	43.14%	43.14%	82.61%	76.33%	57.88%	57.55%
Operating Expenses		(793,340$)	(1,473,608$)	(647,874$)	(427,189$)	(513,325$)	(397,665$)	(331,111$)	(2,958,827$)	606,009$	234,069$	(276,860$)	(1,435,697$)	197,805$
Operating Income		552,712$	528,565$	277,457$	1,959,131$	527,451$	435,747$	269,168$	246,083$	257,910$	55,735$	40,850$	(43,496$)	25,499$
Operating Margin		21.79%	16.33%	13.00%	55.58%	20.56%	24.15%	21.50%	10.93%	12.88%	15.89%	9.82%	(15.58%)	6.57%
Interest Income
Interest Expenses		7,116$	40,274$	31,925$	(324,923$)	43,400$	47,085$	58,022$	(74,097$)	(66,727$)	(70,833$)	(65,573$)	(387,407$)	64,760$
Income Before Tax		542,714$	536,822$	262,772$	1,923,491$	481,474$	405,029$	214,143$	186,995$	(429,349$)	(31,734$)	20,319$	(71,495$)	(16,781$)
Tax Expenses		139,303$	193,942$	148,988$	(1,283,048$)	171,163$	110,681$	126,939$	(213,401$)	63,022$	12,300$	1,969$
Net Income		403,411$	346,566$	113,784$	1,477,209$	310,311$	284,749$	87,204$	98,560$	(492,371$)	(33,164$)	22,288$	(63,658$)	(36,341$)
Profit Margin		15.90%	10.71%	5.33%	41.91%	12.10%	15.78%	6.97%	4.38%	(24.59%)	(9.45%)	5.36%	(22.80%)	(9.37%)
TTM		20.48%	19.61%	21.80%	23.61%	9.92%	(.30%)	(5.80%)	(8.06%)	(18.59%)	(7.73%)
Earnings to Minority
Earnings to Common Shareholders		403,411$	346,566$	113,784$	1,477,209$	310,311$	284,749$	87,204$	98,560$	(492,371$)	(33,164$)	22,288$	(63,658$)	(36,341$)
QoQ%		16.40%	204.58%	(92.30%)	376.04%	8.98%	226.53%	(11.52%)	120.02%	(1,384.66%)	(248.80%)	135.01%	(75.17%)
YoY%		30.00%	21.71%	30.48%	1,398.79%	163.02%	958.61%	291.26%	254.83%	(1,254.86%)
Earnings Per Share, Basic
Earnings Per Share, Diluted
Unlevered FCF Per Share, Basic
Unlevered FCF Per Share, Diluted
Average Shares, Basic
Average Shares, Diluted
EBIT		549,830$	577,096$	294,697$	1,598,568$	524,874$	452,114$	272,165$	112,898$	(496,076$)	(102,567$)	(45,254$)	(458,902$)	47,979$
EBITDA		557,496$	584,593$	302,203$	1,597,911$	550,840$	477,423$	295,393$	146,459$	(484,472$)	(83,964$)	(26,589$)	(469,502$)	58,308$

Copy Table ✓